FORMEL SKIN Secures €33.9M Series A Funding to Transform Digital Dermatology

FORMEL SKIN, an innovative HealthTech start-up revolutionizing the dermatology landscape, proudly announces a significant funding milestone of 33,900,000 raised to date. This success underscores investor confidence in the company’s mission to deliver individualized, high-quality medical treatments online by fusing advanced technology with traditional healthcare expertise. Through an intuitive platform, patients can register online, complete a comprehensive questionnaire, and upload photos of their skin concerns, enabling FORMEL SKIN to assign a personal doctor who determines customized treatment plans. Tailored medications, prepared through partnered pharmacies and conveniently shipped monthly, address patient needs with precision and care. With this new capital infusion, FORMEL SKIN is poised to accelerate its growth and extend its reach across Europe, overcoming current challenges faced by dermatologists and patients alike. The funding will be strategically used to scale the digital platform, enhance data-driven decision-making processes, and drive further innovation in personalized dermatological care. Additionally, the capital will support the expansion of the expert medical team and the refinement of the online consultation experience, ensuring patients receive timely and effective treatment adjustments based on ongoing feedback and results. Having already attracted backing from Europe’s leading early-stage venture capital firms, Cherry Ventures and Heartcore Capital, the current funding round not only fuels operational growth but also reinforces the trust that top investors have in the company's model. As FORMEL SKIN embarks on its next phase of expansion, its commitment to transforming the skin care journey for millions of patients remains steadfast, promising a future filled with enhanced accessibility, responsiveness, and quality in dermatological treatments.